Display options
Cite
Aerts JJ, Plenevaux AR, Lemaire CF, et al. Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats. BMC Med Phys. 2008;8:4doi: 10.1186/1756-6649-8-4.
Aerts, J. J., Plenevaux, A. R., Lemaire, C. F., Giacomelli, F., Warnock, G. I., Phillips, C. L., & Luxen, A. J. (2008). Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats. BMC medical physics, 84. https://doi.org/10.1186/1756-6649-8-4
Aerts, Joël J, et al. "Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats." BMC medical physics vol. 8 (2008): 4. doi: https://doi.org/10.1186/1756-6649-8-4
Aerts JJ, Plenevaux AR, Lemaire CF, Giacomelli F, Warnock GI, Phillips CL, Luxen AJ. Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats. BMC Med Phys. 2008 Nov 07;8:4. doi: 10.1186/1756-6649-8-4. PMID: 18990255; PMCID: PMC2606674.
Copy Download .nbib Format: NLM
Share it on

BMC Med Phys. 2008 Nov 07;8:4. doi: 10.1186/1756-6649-8-4.

Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats.

BMC medical physics

Joël J Aerts, Alain R Plenevaux, Christian F Lemaire, Fabrice Giacomelli, Geoffrey I Warnock, Christophe L Phillips, André J Luxen

Affiliations

  1. Centre de Recherches du Cyclotron, Université de Liège, Liège, Belgique. [email protected]

PMID: 18990255 PMCID: PMC2606674 DOI: 10.1186/1756-6649-8-4

Abstract

BACKGROUND: Several fluorine-18 labelled fluoroamino acids have been evaluated as tracers for the quantitative assessment of cerebral protein synthesis in vivo by positron emission tomography (PET). Among these, 2-[18F]fluoro-L-tyrosine (2-[18F]Tyr) has been studied in mice at a low specific activity. Its incorporation into proteins is fast and metabolism via other pathways is limited. The present in vivo study was carried out in normal awake rats using no-carrier-added 2-[18F]Tyr. Under normal physiological conditions, we have studied the incorporation into proteins and the metabolism of the tracer in different brain areas.

METHODS: No-carrier-added 2-[18F]Tyr was administered to awake rats equipped with chronic arterial and venous catheters. The time course of the plasma activity was studied by arterial blood sampling. The biodistribution of the activity in the main organs was studied at the end of the experiment. The distribution of radioactive species in plasma and brain regions was studied by acidic precipitation of the proteins and HPLC analysis of the supernatant.

RESULTS: The absolute uptake of radioactivity in brain regions was homogenous. In awake rats, no-carrier-added 2-[18F]Tyr exhibits a fast and almost quantitative incorporation into the proteins fractions of cerebellum and cortex. In striatum, this incorporation into proteins and the unchanged fraction of the tracer detected by HPLC could be lower than in other brain regions.

CONCLUSION: This study confirms the potential of 2-[18F]fluoro-L-tyrosine as a tracer for the assessment of the rate of protein synthesis by positron emission tomography. The observed metabolism suggests a need for a correction for the appearance of metabolites, at least in plasma.

References

  1. Eur J Nucl Med Mol Imaging. 2002 May;29(5):681-90 - PubMed
  2. Eur J Nucl Med Mol Imaging. 2005 Dec;32 Suppl 2:S325-45 - PubMed
  3. J Neurosci Methods. 1985 May;13(3-4):213-22 - PubMed
  4. J Nucl Med. 2003 Sep;44(9):1489-94 - PubMed
  5. Pediatr Rehabil. 2006 Apr-Jun;9(2):98-118 - PubMed
  6. J Nucl Med. 1994 Dec;35(12):1996-2002 - PubMed
  7. J Nucl Med. 1989 Aug;30(8):1367-72 - PubMed
  8. Nucl Med Biol. 2006 Apr;33(3):287-94 - PubMed
  9. J Nucl Med. 1993 Nov;34(11):1936-43 - PubMed
  10. Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1182-206 - PubMed
  11. Chem Rev. 2008 May;108(5):1501-16 - PubMed
  12. Science. 2007 Sep 28;317(5846):1881-6 - PubMed
  13. J Nucl Med. 1991 Jul;32(7):1338-46 - PubMed
  14. J Nucl Med. 1998 May;39(5):778-85 - PubMed
  15. Angew Chem Int Ed Engl. 2004 Dec 3;43(47):6426-63 - PubMed
  16. J Nucl Med. 2003 Apr;44(4):533-9 - PubMed

Publication Types